Targeting selectins and selectin ligands in inflammation and cancer

Bibliography

• TOSI MF: Innate immune responses to infection. J. Allergy Clin. Immunol. (2005) 116(2):241-249.
   PubMed Web of Science ®Google Scholar
• SCHON MP, LUDWIG RJ: Lymphocyte trafficking to inflamed skin – molecular mechanisms and implications for therapeutic target molecules. Expert Opin. Ther. Targets (2005) 9(2):225-243.
   PubMed Web of Science ®Google Scholar
• SPRINGER TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell (1994) 76(2):301-314.
   PubMed Web of Science ®Google Scholar
• KELLY M, HWANG JM, KUBES P: Modulating leukocyte recruitment in inflammation. J. Allergy Clin. Immunol. (2007):(In Press).
   Google Scholar
• SIMON SI, GREEN CE: Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu. Rev. Biomed. Eng. (2005) 7:151-185.
   PubMed Web of Science ®Google Scholar
• SACKSTEIN R: The lymphocyte homing receptors: gatekeepers of the multistep paradigm. Curr. Opin. Hematol. (2005) 12(6):444-450.
   PubMed Web of Science ®Google Scholar
• WEBER C, FRAEMOHS L, DEJANA E: The role of junctional adhesion molecules in vascular inflammation. Nat. Rev. Immunol. (2007) 7(6):467-477.
   PubMed Web of Science ®Google Scholar
• FUSTE B, MAZZARA R, ESCOLAR G et al.: Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK. Haematologica (2004) 89(5):578-585.
   PubMed Web of Science ®Google Scholar
• LEY K: The role of selectins in inflammation and disease. Trends Mol. Med. (2003) 9(6):263-268.
   PubMed Web of Science ®Google Scholar
• LUDWIG RJ, SCHON MP, BOEHNCKE WH: P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis. Expert Opin. Ther. Targets (2007) 11(8):1103-1117.
   PubMed Web of Science ®Google Scholar
• ROMANO SJ: Selectin antagonists: therapeutic potential in asthma and COPD. Treat. Respir. Med. (2005) 4(2):85-94.
   PubMedGoogle Scholar
• ROMANO SJ, SLEE DH: Targeting selectins for the treatment of respiratory diseases. Curr. Opin. Investig. Drugs (2001) 2(7):907-913.
   PubMedGoogle Scholar
• SCHON MP, DREWNIOK C, BOEHNCKE WH: Targeting selectin functions in the therapy of psoriasis. Curr. Drug Targets Inflamm. Allergy (2004) 3(2):163-168.
   PubMedGoogle Scholar
• BOCK D, PHILIPP S, WOLFF G: Therapeutic potential of selectin antagonists in psoriasis. Expert Opin. Investig. Drugs (2006) 15(8):963-979.
   PubMed Web of Science ®Google Scholar
• SFIKAKIS PP, MAVRIKAKIS M: Adhesion and lymphocyte costimulatory molecules in systemic rheumatic diseases. Clin. Rheumatol. (1999) 18(4):317-327.
   PubMed Web of Science ®Google Scholar
• WITZ IP: Tumor–microenvironment interactions: the selectin–selectin ligand axis in tumor–endothelium cross talk. Cancer Treat. Res. (2006) 130:125-140.
   PubMedGoogle Scholar
• LAFERRIERE J, HOULE F, HUOT J: Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2/p38. Ann. NY Acad. Sci. (2002) 973:562-572.
   PubMedGoogle Scholar
• WITZ IP: The involvement of selectins and their ligands in tumor-progression. Immunol. Lett. (2006) 104(1-2):89-93.
   PubMed Web of Science ®Google Scholar
• BUTCHER EC, PICKER LJ: Lymphocyte homing and homeostasis. Science (1996) 272(5258):60-66.
   PubMed Web of Science ®Google Scholar
• KANSAS GS: Selectins and their ligands: current concepts and controversies. Blood (1996) 88(9):3259-3287.
   PubMed Web of Science ®Google Scholar
• PATEL KD, NOLLERT MU, MCEVER RP: P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils. J. Cell Biol. (1995) 131(6 Part 2):1893-1902.
   PubMed Web of Science ®Google Scholar
• WENZEL K, FELIX S, KLEBER FX et al.: E-selectin polymorphism and atherosclerosis: an association study. Hum. Mol. Genet. (1994) 3(11):1935-1937.
   PubMedGoogle Scholar
• WENZEL K, HANKE R, SPEER A: Polymorphism in the human E-selectin gene detected by PCR-SSCP. Hum. Genet. (1994) 94(4):452-453.
   PubMed Web of Science ®Google Scholar
• KANSAS GS, SAUNDERS KB, LEY K et al.: A role for the epidermal growth factor-like domain of P-selectin in ligand recognition and cell adhesion. J. Cell Biol. (1994) 124(4):609-618.
   PubMed Web of Science ®Google Scholar
• GIBSON RM, KANSAS GS, TEDDER TF, FURIE B, FURIE BC: Lectin and epidermal growth factor domains of P-selectin at physiologic density are the recognition unit for leukocyte binding. Blood (1995) 85(1):151-158.
   PubMedGoogle Scholar
• LI SH, BURNS DK, RUMBERGER JM et al.: Consensus repeat domains of E-selectin enhance ligand binding. J. Biol. Chem. (1994) 269(6):4431-4437.
   PubMedGoogle Scholar
• GOUVERNEUR M, BERG B, NIEUWDORP M, STROES E, VINK H: Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress. J. Intern. Med. (2006) 259(4):393-400.
   PubMed Web of Science ®Google Scholar
• EHRHARDT C, KNEUER C, BAKOWSKY U: Selectins – an emerging target for drug delivery. Adv. Drug Deliv. Rev. (2004) 56(4):527-549.
   PubMed Web of Science ®Google Scholar
• MOORE KL, EATON SF, LYONS DE et al.: The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine. J. Biol. Chem. (1994) 269(37):23318-23327.
   PubMed Web of Science ®Google Scholar
• MOORE KL: Structure and function of P-selectin glycoprotein ligand-1. Leuk. Lymphoma (1998) 29(1-2):1-15.
   PubMed Web of Science ®Google Scholar
• FUHLBRIGGE RC, KIEFFER JD, ARMERDING D, KUPPER TS: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature (1997) 389(6654):978-981.
   PubMed Web of Science ®Google Scholar
• PICKER LJ, WARNOCK RA, BURNS AR et al.: The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell (1991) 66(5):921-933.
   PubMed Web of Science ®Google Scholar
• ZOLLNER O, LENTER MC, BLANKS JE et al.: L-selectin from human, but not from mouse neutrophils binds directly to E-selectin. J. Cell Biol. (1997) 136(3):707-716.
   PubMedGoogle Scholar
• STEEGMAIER M, LEVINOVITZ A, ISENMANN S et al.: The E-selectin-ligand (ESL-1) is a variant of a receptor for fibroblast growth factor. Nature (1995) 373(6515):615-620.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO M, ATARASHI K, UMEMOTO E et al.: CD43 functions as a ligand for E-selectin on activated T cells. J. Immunol. (2005) 175(12):8042-8050.
   PubMed Web of Science ®Google Scholar
• FUHLBRIGGE RC, KING SL, SACKSTEIN R, KUPPER TS: CD43 is a ligand for E-selectin on CLA+ human T cells. Blood (2006) 107(4):1421-1426.
   PubMed Web of Science ®Google Scholar
• DIMITROFF CJ, LEE JY, RAFII S, FUHLBRIGGE RC, SACKSTEIN R: CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol. (2001) 153(6):1277-1286.
   PubMed Web of Science ®Google Scholar
• KOTOVUORI P, TONTTI E, PIGOTT R et al.: The vascular E-selectin binds to the leukocyte integrins CD11/CD18. Glycobiology (1993) 3(2):131-136.
   PubMed Web of Science ®Google Scholar
• ALON R, FEIZI T, YUEN CT, FUHLBRIGGE RC, SPRINGER TA: Glycolipid ligands for selectins support leukocyte tethering and rolling under physiologic flow conditions. J. Immunol. (1995) 154(10):5356-5366.
   PubMed Web of Science ®Google Scholar
• GOUT S, MORIN C, HOULE F, HUOT J: Death receptor-3, a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res. (2006) 66(18):9117-9124.
   PubMed Web of Science ®Google Scholar
• JONES WM, WATTS GM, ROBINSON MK, VESTWEBER D, JUTILA MA: Comparison of E-selectin-binding glycoprotein ligands on human lymphocytes, neutrophils, and bovine Γδ T cells. J. Immunol. (1997) 159(7):3574-3583.
   PubMedGoogle Scholar
• MONTOYA MC, HOLTMANN K, SNAPP KR et al.: Memory B lymphocytes from secondary lymphoid organs interact with E-selectin through a novel glycoprotein ligand. J. Clin. Invest. (1999) 103(9):1317-1327.
   PubMedGoogle Scholar
• SNAPP KR, DING H, ATKINS K et al.: A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin. Blood (1998) 91(1):154-164.
   PubMed Web of Science ®Google Scholar
• KANAMORI A, KOJIMA N, UCHIMURA K et al.: Distinct sulfation requirements of selectins disclosed using cells that support rolling mediated by all three selectins under shear flow. L-selectin prefers carbohydrate 6-sulfation totyrosine sulfation, whereas P-selectin does not. J. Biol. Chem. (2002) 277(36):32578-32586.
   PubMed Web of Science ®Google Scholar
• RODGERS SD, CAMPHAUSEN RT, HAMMER DA: Tyrosine sulfation enhances but is not required for PSGL-1 rolling adhesion on P-selectin. Biophys. J. (2001) 81(4):2001-2009.
   PubMed Web of Science ®Google Scholar
• LI F, ERICKSON HP, JAMES JA et al.: Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J. Biol. Chem. (1996) 271(11):6342-6348.
   PubMed Web of Science ®Google Scholar
• MOORE KL, PATEL KD, BRUEHL RE et al.: P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J. Cell Biol. (1995) 128(4):661-671.
   PubMed Web of Science ®Google Scholar
• PATEL KD, MOORE KL, NOLLERT MU, MCEVER RP: Neutrophils use both shared and distinct mechanisms to adhere to selectins under static and flow conditions. J. Clin. Invest. (1995) 96(4):1887-1896.
   PubMed Web of Science ®Google Scholar
• WALCHECK B, MOORE KL, MCEVER RP, KISHIMOTO TK: Neutrophil–neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J. Clin. Invest. (1996) 98(5):1081-1087.
   PubMed Web of Science ®Google Scholar
• LIM YC, SNAPP K, KANSAS GS et al.: Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-α-activated endothelium under flow in vitro. J. Immunol. (1998) 161(5):2501-2508.
   PubMedGoogle Scholar
• BORGES E, EYTNER R, MOLL T et al.: The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum. Blood (1997) 90(5):1934-1942.
   PubMedGoogle Scholar
• THATTE A, FICARRO S, SNAPP KR et al.: Binding of function-blocking mAbs to mouse and human P-selectin glycoprotein ligand-1 peptides with and without tyrosine sulfation. J. Leuk. Biol. (2002) 72(3):470-477.
   PubMedGoogle Scholar
• FRENETTE PS, DENIS CV, WEISS L et al.: P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet–endothelial interactions in vivo. J. Exp. Med. (2000) 191(8):1413-1422.
   PubMed Web of Science ®Google Scholar
• NELSON RM, DOLICH S, ARUFFO A, CECCONI O, BEVILACQUA MP: Higher-affinity oligosaccharide ligands for E-selectin. J. Clin. Invest. (1993) 91(3):1157-1166.
   PubMed Web of Science ®Google Scholar
• BRANDLEY BK, KISO M, ABBAS S et al.: Structure–function studies on selectin carbohydrate ligands. Modifications to fucose, sialic acid and sulphate as a sialic acid replacement. Glycobiology (1993) 3(6):633-641.
   PubMed Web of Science ®Google Scholar
• KOENIG A, JAIN R, VIG R et al.: Selectin inhibition: synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of GlyCAM-1. Glycobiology (1997) 7(1):79-93.
   PubMed Web of Science ®Google Scholar
• DUBE DH, BERTOZZI CR: Glycans in cancer and inflammation – potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. (2005) 4(6):477-488.
   PubMed Web of Science ®Google Scholar
• HENNET T: The galactosyltransferase family. Cell Mol. Life Sci. (2002) 59(7):1081-1095.
   PubMed Web of Science ®Google Scholar
• LEY K, KANSAS GS: Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat. Rev. Immunol. (2004) 4(5):325-335.
   PubMed Web of Science ®Google Scholar
• LOWE JB: Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr. Opin. Cell Biol. (2003) 15(5):531-538.
   PubMed Web of Science ®Google Scholar
• SCHOTTELIUS AJ, HAMANN A, ASADULLAH K: Role of fucosyltransferases in leukocyte trafficking: major impact for cutaneous immunity. Trends Immunol. (2003) 24(3):101-104.
   PubMed Web of Science ®Google Scholar
• LOWE JB: Glycosylation in the control of selectin counter – receptor structure and function. Immunol. Rev. (2002) 186:19-36.
   PubMed Web of Science ®Google Scholar
• DE VRIES T, KNEGTEL RM, HOLMES EH, MACHER BA: Fucosyltransferases: structure/function studies. Glycobiology (2001) 11(10):R119-R128.
   Google Scholar
• KUKOWSKA-LATALLO JF, LARSEN RD, NAIR RP, LOWE JB: A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/1,4)fucosyltransferase. Genes Dev. (1990) 4(8):1288-1303.
   PubMed Web of Science ®Google Scholar
• GOELZ SE, HESSION C, GOFF D et al.: ELFT: a gene that directs the expression of an ELAM-1 ligand. Cell (1990) 63(6):1349-1356.
   PubMedGoogle Scholar
• GOELZ S, KUMAR R, POTVIN B et al.: Differential expression of an E-selectin ligand (SLex) by two Chinese hamster ovary cell lines transfected with the same α(1,3)-fucosyltransferase gene (ELFT). J. Biol. Chem. (1994) 269(2):1033-1040.
   PubMedGoogle Scholar
• KUMAR R, POTVIN B, MULLER WA, STANLEY P: Cloning of a human α(1,3)-fucosyltransferase gene that encodes ELFT but does not confer ELAM-1 recognition on Chinese hamster ovary cell transfectants. J. Biol. Chem. (1991) 266(32):21777-21783.
   PubMedGoogle Scholar
• NATSUKA S, GERSTEN KM, ZENITA K, KANNAGI R, LOWE JB: Molecular cloning of a cDNA encoding a novel human leukocyte α-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis X determinant. J. Biol. Chem. (1994) 269(32):20806.
   PubMedGoogle Scholar
• DAGIA NM, GADHOUM SZ, KNOBLAUCH CA et al.: G-CSF induces E-selectin ligand expression on human myeloid cells. Nat. Med. (2006) 12(10):1185-1190.
   PubMedGoogle Scholar
• BROCKHAUSEN I: The role of galactosyltransferases in cell surface functions and in the immune system. Drug News Perspect. (2006) 19(7):401-409.
   PubMed Web of Science ®Google Scholar
• WAGERS AJ, WATERS CM, STOOLMAN LM, KANSAS GS: Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on α1,3-fucosyltransferase VII gene expression. J. Exp. Med. (1998) 188(12):2225-2231.
   PubMed Web of Science ®Google Scholar
• JAIN RK, PISKORZ CF, HUANG BG et al.: Inhibition of L- and P-selectin by a rationally synthesized novel core 2-like branched structure containing GalNAc-Lewisx and Neu5Acα2 – 3Galβ1 – 3GalNAc sequences. Glycobiology (1998) 8(7):707-717.
   PubMed Web of Science ®Google Scholar
• KUMAR R, CAMPHAUSEN RT, SULLIVAN FX, CUMMING DA: Core2 β-1,6-N-acetylglucosaminyltransferase enzyme activity is critical for P-selectin glycoprotein ligand-1 binding to P-selectin. Blood (1996) 88(10):3872-3879.
   PubMedGoogle Scholar
• BURDICK MM, BOCHNER BS, COLLINS BE, SCHNAAR RL, KONSTANTOPOULOS K: Glycolipids support E-selectin-specific strong cell tethering under flow. Biochem. Biophys. Res. Commun. (2001) 284(1):42-49.
   PubMedGoogle Scholar
• SPERANDIO M, THATTE A, FOY D et al.: Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase-deficient mice. Blood (2001) 97(12):3812-3819.
   PubMedGoogle Scholar
• ELLIES LG, SPERANDIO M, UNDERHILL GH et al.: Sialyltransferase specificity in selectin ligand formation. Blood (2002) 100(10):3618-3625.
   PubMed Web of Science ®Google Scholar
• KNIBBS RN, CRAIG RA, NATSUKA S et al.: The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells. J. Cell Biol. (1996) 133(4):911-920.
   PubMedGoogle Scholar
• WAGERS AJ, LOWE JB, KANSAS GS: An important role for the α1,3 fucosyltransferase, FucT-VII, in leukocyte adhesion to E-selectin. Blood (1996) 88(6):2125-2132.
   PubMed Web of Science ®Google Scholar
• KNIBBS RN, CRAIG RA, MALY P et al.: α(1,3)-fucosyltransferase VII-dependent synthesis of P- and E-selectin ligands on cultured T lymphoblasts. J. Immunol. (1998) 161(11):6305-6315.
   PubMedGoogle Scholar
• HUANG MC, LASKOWSKA A, VESTWEBER D, WILD MK: The α(1,3)-fucosyltransferase FucT-IV, but not FucT-VII, generates sialyl Lewis X-like epitopes preferentially on glycolipids. J. Biol. Chem. (2002) 277(49):47786-47795.
   PubMedGoogle Scholar
• KEELAN ET, LICENCE ST, PETERS AM, BINNS RM, HASKARD DO: Characterization of E-selectin expression in vivo with use of a radiolabeled monoclonal antibody. Am. J. Physiol. (1994) 266(1 Part 2):H278-H290.
   PubMedGoogle Scholar
• SCHWEITZER KM, DRAGER AM, VAN DER VALK P et al.: Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am. J. Pathol. (1996) 148(1):165-175.
   PubMed Web of Science ®Google Scholar
• ROCHE WR, MONTEFORT S, BAKER J, HOLGATE ST: Cell adhesion molecules and the bronchial epithelium. Am. Rev. Respir. Dis. (1993) 148(6 Part 2):S79-S82.
   Google Scholar
• COTRAN RS, GIMBRONE MA Jr, BEVILACQUA MP, MENDRICK DL, POBER JS: Induction and detection of a human endothelial activation antigen in vivo. J. Exp. Med. (1986) 164(2):661-666.
   PubMed Web of Science ®Google Scholar
• MUNRO JM, POBER JS, COTRAN RS: TNF and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am. J. Pathol. (1989) 135(1):121-133.
   PubMed Web of Science ®Google Scholar
• PICKER LJ, KISHIMOTO TK, SMITH CW, WARNOCK RA, BUTCHER EC: ELAM-1 is an adhesion molecule for skin-homing T cells. Nature (1991) 349(6312):796-799.
   PubMed Web of Science ®Google Scholar
• BEVILACQUA MP, POBER JS, MENDRICK DL, COTRAN RS, GIMBRONE MA Jr: Identification of an inducible endothelial–leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA (1987) 84(24):9238-9242.
   PubMed Web of Science ®Google Scholar
• HARALDSEN G, KVALE D, LIEN B, FARSTAD IN, BRANDTZAEG P: Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J. Immunol. (1996) 156(7):2558-2565.
   PubMed Web of Science ®Google Scholar
• GHERSA P, HOOFT VAN HUIJSDUIJNEN R, WHELAN J, DELAMARTER JF: Labile proteins play a dual role in the control of endothelial leukocyte adhesion molecule-1 (ELAM-1) gene regulation. J. Biol. Chem. (1992) 267(27):19226-19232.
   PubMedGoogle Scholar
• SUBRAMANIAM M, KOEDAM JA, WAGNER DD: Divergent fates of P- and E-selectins after their expression on the plasma membrane. Mol. Biol. Cell (1993) 4(8):791-801.
   PubMed Web of Science ®Google Scholar
• JENSEN LE, WHITEHEAD AS: ELAM-1/E-selectin promoter contains an inducible AP-1/CREB site and is not NF-κB-specific. Biotechniques (2003) 35(1):54-56, 58.
   PubMedGoogle Scholar
• ISHII H, TAKADA K: Bleomycin induces E-selectin expression in cultured umbilical vein endothelial cells by increasing its mRNA levels through activation of NF-κB/Rel. Toxicol. Appl. Pharmacol. (2002) 184(2):88-97.
   PubMedGoogle Scholar
• LOEWE R, PILLINGER M, DE MARTIN R et al.: Dimethylfumarate inhibits TNF-induced CD62E expression in an NF-κB-dependent manner. J. Invest. Dermatol. (2001) 117(6):1363-1368.
   PubMed Web of Science ®Google Scholar
• BEVILACQUA MP, STENGELIN S, GIMBRONE MA JR, SEED B: Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science (1989) 243(4895):1160-1165.
   PubMed Web of Science ®Google Scholar
• GAMBLE JR, KHEW-GOODALL Y, VADAS MA: Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J. Immunol. (1993) 150(10):4494-4503.
   PubMed Web of Science ®Google Scholar
• LANGE PH, VESSELLA RL: Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone. Cancer Metast. Rev. (1998) 17(4):331-336.
   PubMed Web of Science ®Google Scholar
• YIN JJ, POLLOCK CB, KELLY K: Mechanisms of cancer metastasis to the bone. Cell Res. (2005) 15(1):57-62.
   PubMed Web of Science ®Google Scholar
• SACKSTEIN R: The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing. J. Investig. Dermatol. Symp. Proc. (2004) 9(3):215-223.
   PubMedGoogle Scholar
• GRAVES BJ, CROWTHER RL, CHANDRAN C et al.: Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Nature (1994) 367(6463):532-538.
   PubMed Web of Science ®Google Scholar
• ETZIONI A, FRYDMAN M, POLLACK S et al.: Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl. J. Med. (1992) 327(25):1789-1792.
   PubMed Web of Science ®Google Scholar
• VON ANDRIAN UH, BERGER EM, RAMEZANI L et al.: In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes. J. Clin. Invest. (1993) 91(6):2893-2897.
   PubMedGoogle Scholar
• HELLBUSCH CC, SPERANDIO M, FROMMHOLD D et al.: Golgi GDP-fucose transporter-deficient mice mimic congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II. J. Biol. Chem. (2007) 282(14):10762-10772.
   PubMedGoogle Scholar
• SMITH PL, MYERS JT, ROGERS CE et al.: Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J. Cell Biol. (2002) 158(4):801-815.
   PubMed Web of Science ®Google Scholar
• MARQUARDT T, LUHN K, SRIKRISHNA G et al.: Correction of leukocyte adhesion deficiency type II with oral fucose. Blood (1999) 94(12):3976-3985.
   PubMed Web of Science ®Google Scholar
• BECKER DJ, LOWE JB: Fucose: biosynthesis and biological function in mammals. Glycobiology (2003) 13(7):R41-R53.
   PubMed Web of Science ®Google Scholar
• YAKUBENIA S, WILD MK: Leukocyte adhesion deficiency II. Advances and open questions. FEBS J. (2006) 273(19):4390-4398.
   PubMedGoogle Scholar
• BECKER DJ, LOWE JB: Leukocyte adhesion deficiency type II. Biochim. Biophys. Acta (1999) 1455(2-3):193-204.
   PubMedGoogle Scholar
• WENINGER W, ULFMAN LH, CHENG G et al.: Specialized contributions by α(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity (2000) 12(6):665-676.
   PubMed Web of Science ®Google Scholar
• SMITHSON G, ROGERS CE, SMITH PL et al.: FucT-VII is required for T helper 1 and T cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with FucT-IV regulates naive T cell trafficking to lymph nodes. J. Exp. Med. (2001) 194(5):601-614.
   PubMed Web of Science ®Google Scholar
• HOMEISTER JW, THALL AD, PETRYNIAK B et al.: The α(1,3) fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity (2001) 15(1):115-126.
   PubMed Web of Science ®Google Scholar
• YOSHIDA M, SZENTE BE, KIELY JM, ROSENZWEIG A, GIMBRONE MA Jr: Phosphorylation of the cytoplasmic domain of E-selectin is regulated during leukocyte–endothelial adhesion. J. Immunol. (1998) 161(2):933-941.
   PubMedGoogle Scholar
• HU Y, KIELY JM, SZENTE BE, ROSENZWEIG A, GIMBRONE MA Jr: E-selectin-dependent signaling via the mitogen-activated protein kinase pathway in vascular endothelial cells. J. Immunol. (2000) 165(4):2142-2148.
   PubMedGoogle Scholar
• HU Y, SZENTE B, KIELY JM, GIMBRONE MA Jr: Molecular events in transmembrane signaling via E-selectin. SHP2 association, adaptor protein complex formation and ERK1/2 activation. J. Biol. Chem. (2001) 276(51):48549-48553.
   PubMedGoogle Scholar
• YOSHIDA M, WESTLIN WF, WANG N et al.: Leukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeleton. J. Cell Biol. (1996) 133(2):445-455.
   PubMed Web of Science ®Google Scholar
• KAPLANSKI G, FARNARIER C, BENOLIEL AM et al.: A novel role for E- and P-selectins: shape control of endothelial cell monolayers. J. Cell Sci. (1994) 107(Part 9):2449-2457.
   PubMed Web of Science ®Google Scholar
• TREMBLAY PL, AUGER FA, HUOT J: Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene (2006) 25(50):6563-6573.
   PubMed Web of Science ®Google Scholar
• HIDALGO A, PEIRED AJ, WILD MK, VESTWEBER D, FRENETTE PS: Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity (2007) 26(4):477-489.
   PubMed Web of Science ®Google Scholar
• LO SK, LEE S, RAMOS RA et al.: Endothelial–leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, αm β2) on human neutrophils. J. Exp. Med. (1991) 173(6):1493-1500.
   PubMed Web of Science ®Google Scholar
• GREEN CE, PEARSON DN, CAMPHAUSEN RT, STAUNTON DE, SIMON SI: Shear-dependent capping of L-selectin and P-selectin glycoprotein ligand 1 by E-selectin signals activation of high-avidity β2-integrin on neutrophils. J. Immunol. (2004) 172(12):7780-7790.
   PubMed Web of Science ®Google Scholar
• HENTZEN E, MCDONOUGH D, MCINTIRE L et al.: Hydrodynamic shear and tethering through E-selectin signals phosphorylation of p38 MAP kinase and adhesion of human neutrophils. Ann. Biomed. Eng. (2002) 30(8):987-1001.
   PubMed Web of Science ®Google Scholar
• SIMON SI, HU Y, VESTWEBER D, SMITH CW: Neutrophil tethering on E-selectin activates β2 integrin binding to ICAM-1 through a mitogen-activated protein kinase signal transduction pathway. J. Immunol. (2000) 164(8):4348-4358.
   PubMed Web of Science ®Google Scholar
• PICADO C: Early and late-phase asthmatic reactions: a hypothesis. Allergy (1992) 47(4 Part 1):331-333.
   PubMed Web of Science ®Google Scholar
• PAWANKAR R, YAMAGISHI S, TAKIZAWA R, YAGI T: Mast cell–IgE- and mast cell–structural cell interactions in allergic airway disease. Curr. Drug Targets Inflamm. Allergy (2003) 2(4):303-312.
   PubMedGoogle Scholar
• KUPPER TS, FUHLBRIGGE RC: Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. (2004) 4(3):211-222.
   PubMed Web of Science ®Google Scholar
• PIGOTT R, DILLON LP, HEMINGWAY IH, GEARING AJ: Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun. (1992) 187(2):584-589.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI T, HASHIMOTO S, IMAI K et al.: Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin. Exp. Immunol. (1994) 96(1):110-115.
   PubMed Web of Science ®Google Scholar
• JANSON C, LUDVIKSDOTTIR D, GUNNBJORNSDOTTIR M et al.: Circulating adhesion molecules in allergic and non-allergic asthma. Respir. Med. (2005) 99(1):45-51.
   PubMedGoogle Scholar
• KOWALZICK L, KLEINHEINZ A, NEUBER K et al.: Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment. Dermatology (1995) 190(1):14-18.
   PubMedGoogle Scholar
• KRASOWSKA D, PIETRZAK A, LECEWICZ-TORUN B: Serum level of sELAM-1 in psoriatic patients correlates with disease activity. J. Eur. Acad. Dermatol. Venereol. (1999) 12(2):140-142.
   PubMed Web of Science ®Google Scholar
• SZEPIETOWSKI J, WASIK F, BIELICKA E, NOCKOWSKI P, NOWOROLSKA A: Soluble E-selectin serum levels correlate with disease activity in psoriatic patients. Clin. Exp. Dermatol. (1999) 24(1):33-36.
   PubMed Web of Science ®Google Scholar
• CZECH W, SCHOPF E, KAPP A: Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis – correlation with disease activity. Br. J. Dermatol. (1996) 134(1):17-21.
   PubMed Web of Science ®Google Scholar
• BALLMER-WEBER BK, BRAATHEN LR, BRAND CU: sICAM-1, sE-selectin and sVCAM-1 are constitutively present in human skin lymph and increased in allergic contact dermatitis. Arch. Dermatol. Res. (1997) 289(5):251-255.
   PubMedGoogle Scholar
• KOIDE M, FURUKAWA F, TOKURA Y, SHIRAHAMA S, TAKIGAWA M: Evaluation of soluble cell adhesion molecules in atopic dermatitis. J. Dermatol. (1997) 24(2):88-93.
   PubMedGoogle Scholar
• WOLKERSTORFER A, SAVELKOUL HF, DE WAARD VAN DER SPEK FB et al.: Soluble E-selectin and soluble ICAM-1 levels as markers of the activity of atopic dermatitis in children. Pediatr. Allergy Immunol. (2003) 14(4):302-306.
   PubMedGoogle Scholar
• WOLKERSTORFER A, LAAN MP, SAVELKOUL HF et al.: Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis. Br. J. Dermatol. (1998) 138(3):431-435.
   PubMedGoogle Scholar
• KIM DS, LEE KY: Serum soluble E-selectin levels in Kawasaki disease. Scand. J. Rheumatol. (1994) 23(5):283-286.
   PubMed Web of Science ®Google Scholar
• OKA N, AKIGUCHI I, KAWASAKI T, OHNISHI K, KIMURA J: Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Ann. Neurol. (1994) 35(5):621-624.
   PubMedGoogle Scholar
• WENISCH C, MYSKIW D, PARSCHALK B et al.: Soluble endothelium-associated adhesion molecules in patients with Graves' disease. Clin. Exp. Immunol. (1994) 98(2):240-244.
   PubMedGoogle Scholar
• BODARY PF, HOMEISTER JW, VARGAS FB et al.: Generation of soluble P- and E-selectins in vivo is dependent on expression of P-selectin glycoprotein ligand-1. J. Thromb. Haemost. (2007) 5(3):599-603.
   PubMedGoogle Scholar
• RUCHAUD-SPARAGANO MH, DROST EM, DONNELLY SC et al.: Potential pro-inflammatory effects of soluble E-selectin upon neutrophil function. Eur. J. Immunol. (1998) 28(1):80-89.
   PubMed Web of Science ®Google Scholar
• BHUSHAN M, BLEIKER TO, BALLSDON AE et al.: Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial. Br. J. Dermatol. (2002) 146(5):824-831.
   PubMed Web of Science ®Google Scholar
• JUNG K, LINSE F, PALS ST et al.: Adhesion molecules in atopic dermatitis: patch tests elicited by house dust mite. Contact Dermatitis (1997) 37(4):163-172.
   PubMedGoogle Scholar
• SILBER A, NEWMAN W, REIMANN KA et al.: Kinetic expression of endothelial adhesion molecules and relationship to leukocyte recruitment in two cutaneous models of inflammation. Lab. Invest. (1994) 70(2):163-175.
   PubMed Web of Science ®Google Scholar
• GOSSET P, TILLIE-LEBLOND I, JANIN A et al.: Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int. Arch. Allergy Immunol. (1995) 106(1):69-77.
   PubMedGoogle Scholar
• BENTLEY AM, DURHAM SR, ROBINSON DS et al.: Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J. Allergy Clin. Immunol. (1993) 92(6):857-868.
   PubMed Web of Science ®Google Scholar
• MILSTONE DS, FUKUMURA D, PADGETT RC et al.: Mice lacking E-selectin show normal numbers of rolling leukocytes but reduced leukocyte stable arrest on cytokine-activated microvascular endothelium. Microcirculation (1998) 5(2-3):153-171.
   PubMedGoogle Scholar
• RAMOS CL, KUNKEL EJ, LAWRENCE MB et al.: Differential effect of E-selectin antibodies on neutrophil rolling and recruitment to inflammatory sites. Blood (1997) 89(8):3009-3018.
   PubMedGoogle Scholar
• KUNKEL EJ, DUNNE JL, LEY K: Leukocyte arrest during cytokine-dependent inflammation in vivo. J. Immunol. (2000) 164(6):3301-3308.
   PubMedGoogle Scholar
• LEY K, ALLIETTA M, BULLARD DC, MORGAN S: Importance of E-selectin for firm leukocyte adhesion in vivo. Circ. Res. (1998) 83(3):287-294.
   PubMedGoogle Scholar
• SUBRAMANIAM M, SAFFARIPOUR S, VAN DE WATER L et al.: Role of endothelial selectins in wound repair. Am. J. Pathol. (1997) 150(5):1701-1709.
   PubMed Web of Science ®Google Scholar
• SANTAMARIA BABI LF, PICKER LJ, PEREZ SOLER MT et al.: Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J. Exp. Med. (1995) 181(5):1935-1940.
   PubMed Web of Science ®Google Scholar
• STAITE ND, JUSTEN JM, SLY LM, BEAUDET AL, BULLARD DC: Inhibition of delayed-type contact hypersensitivity in mice deficient in both E-selectin and P-selectin. Blood (1996) 88(8):2973-2979.
   PubMed Web of Science ®Google Scholar
• AUSTRUP F, VESTWEBER D, BORGES E et al.: P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature (1997) 385(6611):81-83.
   PubMed Web of Science ®Google Scholar
• CATALINA MD, ESTESS P, SIEGELMAN MH: Selective requirements for leukocyte adhesion molecules in models of acute and chronic cutaneous inflammation: participation of E- and P- but not L-selectin. Blood (1999) 93(2):580-589.
   PubMed Web of Science ®Google Scholar
• MCMURRAY RW: Adhesion molecules in autoimmune disease. Semin. Arthritis Rheum. (1996) 25(4):215-233.
   PubMed Web of Science ®Google Scholar
• ROSEN SD, SINGER MS, YEDNOCK TA, STOOLMAN LM: Involvement of sialic acid on endothelial cells in organ-specific lymphocyte recirculation. Science (1985) 228(4702):1005-1007.
   PubMedGoogle Scholar
• WALZ G, ARUFFO A, KOLANUS W, BEVILACQUA M, SEED B: Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science (1990) 250(4984):1132-1135.
   PubMed Web of Science ®Google Scholar
• PICKER LJ, MICHIE SA, ROTT LS, BUTCHER EC: A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am. J. Pathol. (1990) 136(5):1053-1068.
   PubMed Web of Science ®Google Scholar
• BERG EL, YOSHINO T, ROTT LS et al.: The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell–leukocyte adhesion molecule 1. J. Exp. Med. (1991) 174(6):1461-1466.
   PubMed Web of Science ®Google Scholar
• BERG EL, ROBINSON MK, MANSSON O, BUTCHER EC, MAGNANI JL: A carbohydrate domain common to both sialyl Le(a) and sialyl Le(X) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J. Biol. Chem. (1991) 266(23):14869-14872.
   PubMed Web of Science ®Google Scholar
• ALON R, ROSSITER H, WANG X, SPRINGER TA, KUPPER TS: Distinct cell surface ligands mediate T lymphocyte attachment and rolling on P and E selectin under physiological flow. J. Cell Biol. (1994) 127(5):1485-1495.
   PubMed Web of Science ®Google Scholar
• SUEYOSHI S, TSUBOI S, SAWADA-HIRAI R et al.: Expression of distinct fucosylated oligosaccharides and carbohydrate-mediated adhesion efficiency directed by two different α-1,3-fucosyltransferases. Comparison of E- and L-selectin-mediated adhesion. J. Biol. Chem. (1994) 269(51):32342-32350.
   PubMedGoogle Scholar
• BERG EL, MULLOWNEY AT, ANDREW DP, GOLDBERG JE, BUTCHER EC: Complexity and differential expression of carbohydrate epitopes associated with L-selectin recognition of high endothelial venules. Am. J. Pathol. (1998) 152(2):469-477.
   PubMed Web of Science ®Google Scholar
• SACKSTEIN R, DIMITROFF CJ: A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity. Blood (2000) 96(8):2765-2774.
   PubMed Web of Science ®Google Scholar
• DIMITROFF CJ, LEE JY, FUHLBRIGGE RC, SACKSTEIN R: A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc. Natl. Acad. Sci. USA (2000) 97(25):13841-13846.
   PubMedGoogle Scholar
• DIMITROFF CJ, LEE JY, SCHOR KS, SANDMAIER BM, SACKSTEIN R: differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1. J. Biol. Chem. (2001) 276(50):47623-47631.
   PubMedGoogle Scholar
• DAVIS RE, SMOLLER BR: T lymphocytes expressing HECA-452 epitope are present in cutaneous acute graft-versus-host disease and erythema multiforme, but not in acute graft-versus-host disease in gut organs. Am. J. Pathol. (1992) 141(3):691-698.
   PubMed Web of Science ®Google Scholar
• ROSSITER H, VAN REIJSEN F, MUDDE GC et al.: Skin disease-related T cells bind to endothelial selectins: expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur. J. Immunol. (1994) 24(1):205-210.
   PubMed Web of Science ®Google Scholar
• ROOK AH, HEALD P: The immunopathogenesis of cutaneous T-cell lymphoma. Hematol. Oncol. Clin. North Am. (1995) 9(5):997-1010.
   PubMed Web of Science ®Google Scholar
• FUHLBRIGGE RC, KING SL, DIMITROFF CJ, KUPPER TS, SACKSTEIN R: Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots. J. Immunol. (2002) 168(11):5645-5651.
   PubMedGoogle Scholar
• BOROWITZ MJ, WEIDNER A, OLSEN EA, PICKER LJ: Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease. Leukemia (1993) 7(6):859-863.
   PubMed Web of Science ®Google Scholar
• FERENCZI K, FUHLBRIGGE RC, PINKUS J, PINKUS GS, KUPPER TS: Increased CCR4 expression in cutaneous T cell lymphoma. J. Invest. Dermatol. (2002) 119(6):1405-1410.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI T, OHSHIMA K, TSUCHIYA T et al.: The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2-associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia/lymphoma. Eur. J. Dermatol. (2003) 13(6):553-559.
   PubMed Web of Science ®Google Scholar
• DUIJVESTIJN AM, HORST E, PALS ST et al.: High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am. J. Pathol. (1988) 130(1):147-155.
   PubMed Web of Science ®Google Scholar
• HUNGER RE, YAWALKAR N, BRAATHEN LR, BRAND CU: The HECA-452 epitope is highly expressed on lymph cells derived from human skin. Br. J. Dermatol. (1999) 141(3):565-569.
   PubMedGoogle Scholar
• DIMITROFF CJ, BERNACKI RJ, SACKSTEIN R: Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin. Blood (2003) 101(2):602-610.
   PubMed Web of Science ®Google Scholar
• BLANDER JM, VISINTIN I, JANEWAY CA Jr, MEDZHITOV R: α(1,3)-Fucosyltransferase VII and α(2,3)-sialyltransferase IV are up-regulated in activated CD4 T cells and maintained after their differentiation into Th1 and migration into inflammatory sites. J. Immunol. (1999) 163(7):3746-3752.
   PubMedGoogle Scholar
• WAGERS AJ, KANSAS GS: Potent induction of α(1,3)-fucosyltransferase VII in activated CD4+ T cells by TGF-β1 through a p38 mitogen-activated protein kinase-dependent pathway. J. Immunol. (2000) 165(9):5011-5016.
   PubMedGoogle Scholar
• LOWE JB, STOOLMAN LM, NAIR RP et al.: ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell (1990) 63(3):475-484.
   PubMed Web of Science ®Google Scholar
• MALY P, THALL A, PETRYNIAK B et al.: The α(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell (1996) 86(4):643-653.
   PubMed Web of Science ®Google Scholar
• ELLIES LG, TSUBOI S, PETRYNIAK B et al.: Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity (1998) 9(6):881-890.
   PubMed Web of Science ®Google Scholar
• ASANO M, NAKAE S, KOTANI N et al.: Impaired selectin-ligand biosynthesis and reduced inflammatory responses in β-1,4-galactosyltransferase-I-deficient mice. Blood (2003) 102(5):1678-1685.
   PubMed Web of Science ®Google Scholar
• AINSLIE MP, MCNULTY CA, HUYNH T, SYMON FA, WARDLAW AJ: Characterisation of adhesion receptors mediating lymphocyte adhesion to bronchial endothelium provides evidence for a distinct lung homing pathway. Thorax (2002) 57(12):1054-1059.
   PubMed Web of Science ®Google Scholar
• WOLBER FM, CURTIS JL, MALY P et al.: Endothelial selectins and α4 integrins regulate independent pathways of T lymphocyte recruitment in the pulmonary immune response. J. Immunol. (1998) 161(8):4396-4403.
   PubMed Web of Science ®Google Scholar
• CURTIS JL, SONSTEIN J, CRAIG RA et al.: Subset-specific reductions in lung lymphocyte accumulation following intratracheal antigen challenge in endothelial selectin-deficient mice. J. Immunol. (2002) 169(5):2570-2579.
   PubMedGoogle Scholar
• LUKACS NW, JOHN A, BERLIN A et al.: E- and P-selectins are essential for the development of cockroach allergen-induced airway responses. J. Immunol. (2002) 169(4):2120-2125.
   PubMed Web of Science ®Google Scholar
• DONG ZM, BROWN AA, WAGNER DD: Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation (2000) 101(19):2290-2295.
   PubMed Web of Science ®Google Scholar
• MANKA D, COLLINS RG, LEY K, BEAUDET AL, SAREMBOCK IJ: Absence of P-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein E-deficient mice. Circulation (2001) 103(7):1000-1005.
   PubMed Web of Science ®Google Scholar
• CAMERON MD, SCHMIDT EE, KERKVLIET N et al.: Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. (2000) 60(9):2541-2546.
   PubMed Web of Science ®Google Scholar
• KRAUSE T, TURNER GA: Are selectins involved in metastasis? Clin. Exp. Metast. (1999) 17(3):183-192.
   PubMedGoogle Scholar
• BURDICK MM, CHU JT, GODAR S, SACKSTEIN R: HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. J. Biol. Chem. (2006) 281(20):13899-13905.
   PubMed Web of Science ®Google Scholar
• HANLEY WD, NAPIER SL, BURDICK MM et al.: Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. FASEB J. (2006) 20(2):337-339.
   PubMedGoogle Scholar
• HANLEY WD, BURDICK MM, KONSTANTOPOULOS K, SACKSTEIN R: CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Res. (2005) 65(13):5812-5817.
   PubMed Web of Science ®Google Scholar
• BURDICK MM, MCCAFFERY JM, KIM YS, BOCHNER BS, KONSTANTOPOULOS K: Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am. J. Physiol. Cell Physiol. (2003) 284(4):C977-C987.
   Google Scholar
• LAFERRIERE J, HOULE F, HUOT J: Adhesion of HT-29 colon carcinoma cells to endothelial cells requires sequential events involving E-selectin and integrin β4. Clin. Exp. Metast. (2004) 21(3):257-264.
   PubMed Web of Science ®Google Scholar
• LAFERRIERE J, HOULE F, TAHER MM, VALERIE K, HUOT J: Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J. Biol. Chem. (2001) 276(36):33762-33772.
   PubMed Web of Science ®Google Scholar
• SOLTESZ SA, POWERS EA, GENG JG, FISHER C: Adhesion of HT-29 colon carcinoma cells to E-selectin results in increased tyrosine phosphorylation and decreased activity of c-src. Int. J. Cancer (1997) 71(4):645-653.
   PubMedGoogle Scholar
• HILLER KM, MAYBEN JP, BENDT KM et al.: Transfection of α(1,3)fucosyltransferase antisense sequences impairs the proliferative and tumorigenic ability of human colon carcinoma cells. Mol. Carcinog. (2000) 27(4):280-288.
   PubMedGoogle Scholar
• WESTON BW, HILLER KM, MAYBEN JP et al.: Expression of human α(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. Cancer Res. (1999) 59(9):2127-2135.
   PubMedGoogle Scholar
• FLUGY AM, D'AMATO M, RUSSO D et al.: E-selectin modulates the malignant properties of T84 colon carcinoma cells. Biochem. Biophys. Res. Commun. (2002) 293(3):1099-1106.
   PubMedGoogle Scholar
• DI BELLA MA, FLUGY AM, RUSSO D et al.: Different phenotypes of colon carcinoma cells interacting with endothelial cells: role of E-selectin and ultrastructural data. Cell Tissue Res. (2003) 312(1):55-64.
   PubMedGoogle Scholar
• SAWADA R, TSUBOI S, FUKUDA M: Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J. Biol. Chem. (1994) 269(2):1425-1431.
   PubMedGoogle Scholar
• SRINIVAS U, PAHLSSON P, LUNDBLAD A: E-selectin: sialyl Lewis, a dependent adhesion of colon cancer cells, is inhibited differently by antibodies against E-selectin ligands. Scand. J. Immunol. (1996) 44(3):197-203.
   PubMed Web of Science ®Google Scholar
• KIM YJ, BORSIG L, HAN HL, VARKI NM, VARKI A: Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am. J. Pathol. (1999) 155(2):461-472.
   PubMed Web of Science ®Google Scholar
• MANNORI G, CROTTET P, CECCONI O et al.: Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res. (1995) 55(19):4425-4431.
   PubMed Web of Science ®Google Scholar
• DEJANA E, MARTIN-PADURA I, LAURI D et al.: Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain. Lab. Invest. (1992) 66(3):324-330.
   PubMed Web of Science ®Google Scholar
• YAMADA N, CHUNG YS, SAWADA T, OKUNO M, SOWA M: Role of SPan-1 antigen in adhesion of human colon cancer cells to vascular endothelium. Dig. Dis. Sci. (1995) 40(5):1005-1012.
   PubMedGoogle Scholar
• CHO M, DAHIYA R, CHOI SR et al.: Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma. Eur. J. Cancer (1997) 33(6):931-941.
   PubMedGoogle Scholar
• NAKAMORI S, KAMEYAMA M, IMAOKA S et al.: Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis. Dis. Colon Rectum (1997) 40(4):420-431.
   PubMed Web of Science ®Google Scholar
• BRODT P, FALLAVOLLITA L, BRESALIER RS et al.: Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int. J. Cancer (1997) 71(4):612-619.
   PubMed Web of Science ®Google Scholar
• BRESALIER RS, BYRD JC, BRODT P et al.: Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length. Int. J. Cancer (1998) 76(4):556-562.
   PubMed Web of Science ®Google Scholar
• DIMITROFF CJ, LECHPAMMER M, LONG-WOODWARD D, KUTOK JL: Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res. (2004) 64(15):5261-5269.
   PubMed Web of Science ®Google Scholar
• TOZEREN A, KLEINMAN HK, GRANT DS et al.: E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int. J. Cancer (1995) 60(3):426-431.
   PubMed Web of Science ®Google Scholar
• NARITA T, KAWASAKI-KIMURA N, MATSUURA N, FUNAHASHI H, KANNAGI R: Adhesion of human breast cancer cells to vascular endothelium mediated by sialyl Lewis &supx/E-selectin. Breast Cancer (1996) 3(1):19-23.
   PubMedGoogle Scholar
• MOSS MA, ZIMMER S, ANDERSON KW: Role of metastatic potential in the adhesion of human breast cancer cells to endothelial monolayers. Anticancer Res. (2000) 20(3A):1425-1433.
   PubMedGoogle Scholar
• LAFRENIE RM, GALLO S, PODOR TJ, BUCHANAN MR, ORR FW: The relative roles of vitronectin receptor, E-selectin and α4β1 in cancer cell adhesion to interleukin-1-treated endothelial cells. Eur. J. Cancer (1994) 30A(14):2151-2158.
   PubMedGoogle Scholar
• IWAI K, ISHIKURA H, KAJI M et al.: Importance of E-selectin (ELAM-1) and sialyl Lewis(a) in the adhesion of pancreatic carcinoma cells to activated endothelium. Int. J. Cancer (1993) 54(6):972-977.
   PubMedGoogle Scholar
• MARTIN-SATUE M, MARRUGAT R, CANCELAS JA, BLANCO J: Enhanced expression of α(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. Cancer Res. (1998) 58(7):1544-1550.
   PubMed Web of Science ®Google Scholar
• MARTIN-SATUE M, DE CASTELLARNAU C, BLANCO J: Overexpression of α(1,3)-fucosyltransferase VII is sufficient for the acquisition of lung colonization phenotype in human lung adenocarcinoma HAL-24Luc cells. Br. J. Cancer (1999) 80(8):1169-1174.
   PubMedGoogle Scholar
• REDDI AH, ROODMAN D, FREEMAN C, MOHLA S: Mechanisms of tumor metastasis to the bone: challenges and opportunities. J. Bone Miner. Res. (2003) 18(2):190-194.
   PubMed Web of Science ®Google Scholar
• LEHR JE, PIENTA KJ: Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J. Natl. Cancer Inst. (1998) 90(2):118-123.
   PubMedGoogle Scholar
• SCOTT LJ, CLARKE NW, GEORGE NJ et al.: Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br. J. Cancer (2001) 84(10):1417-1423.
   PubMed Web of Science ®Google Scholar
• SIMPSON MA, REILAND J, BURGER SR et al.: Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells. J. Biol. Chem. (2001) 276(21):17949-17957.
   PubMedGoogle Scholar
• COOPER CR, MCLEAN L, WALSH M et al.: Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro. Clin. Cancer Res. (2000) 6(12):4839-4847.
   PubMedGoogle Scholar
• ZIPIN A, ISRAELI-AMIT M, MESHEL T et al.: Tumor–microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells. Cancer Res. (2004) 64(18):6571-6578.
   PubMedGoogle Scholar
• BIANCONE L, ARAKI M, ARAKI K, VASSALLI P, STAMENKOVIC I: Redirection of tumor metastasis by expression of E-selectin in vivo. J. Exp. Med. (1996) 183(2):581-587.
   PubMed Web of Science ®Google Scholar
• RENKONEN J, PAAVONEN T, RENKONEN R: Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int. J. Cancer (1997) 74(3):296-300.
   PubMed Web of Science ®Google Scholar
• HOFF SD, MATSUSHITA Y, OTA DM et al.: Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res. (1989) 49(24 Part 1):6883-6888.
   PubMedGoogle Scholar
• NAKAMORI S, FURUKAWA H, HIRATSUKA M et al.: Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer. J. Clin. Oncol. (1997) 15(2):816-825.
   PubMed Web of Science ®Google Scholar
• KISHIMOTO T, ISHIKURA H, KIMURA C et al.: Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen. Int. J. Cancer (1996) 69(4):290-294.
   PubMed Web of Science ®Google Scholar
• DIMITROFF CJ, DESCHENY L, TRUJILLO N et al.: Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res. (2005) 65(13):5750-5760.
   PubMedGoogle Scholar
• JORGENSEN T, BERNER A, KAALHUS O et al.: Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer. Cancer Res. (1995) 55(9):1817-1819.
   PubMed Web of Science ®Google Scholar
• MATSUURA N, NARITA T, MITSUOKA C et al.: Increased concentration of soluble E-selectin in the sera of breast cancer patients. Anticancer Res. (1997) 17(2B):1367-1372.
   PubMed Web of Science ®Google Scholar
• FOX SB, TURNER GD, LEEK RD et al.: The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Res. Treat. (1995) 36(2):219-226.
   PubMed Web of Science ®Google Scholar
• YE C, KIRIYAMA K, MISTUOKA C et al.: Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int. J. Cancer (1995) 61(4):455-460.
   PubMed Web of Science ®Google Scholar
• SCHADENDORF D, HEIDEL J, GAWLIK C, SUTER L, CZARNETZKI BM: Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J. Natl. Cancer Inst. (1995) 87(5):366-371.
   PubMedGoogle Scholar
• ALLEN MH, ROBINSON MK, STEPHENS PE, MACDONALD DM, BARKER JN: E-selectin binds to squamous cell carcinoma and keratinocyte cell lines. J. Invest. Dermatol. (1996) 106(4):611-615.
   PubMedGoogle Scholar
• NARITA T, KAWAKAMI-KIMURA N, MATSUURA N, HOSONO J, KANNAGI R: Corticosteroids and medroxyprogesterone acetate inhibit the induction of E-selectin on the vascular endothelium by MDA-MB-231 breast cancer cells. Anticancer Res. (1995) 15(6B):2523-2527.
   PubMedGoogle Scholar
• BALKWILL F, MANTOVANI A: Inflammation and cancer: back to Virchow? Lancet (2001) 357(9255):539-545.
   PubMed Web of Science ®Google Scholar
• NIESWANDT B, HAFNER M, ECHTENACHER B, MANNEL DN: Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. (1999) 59(6):1295-1300.
   PubMed Web of Science ®Google Scholar
• BORSIG L, WONG R, FERAMISCO J et al.: Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci. USA (2001) 98(6):3352-3357.
   PubMed Web of Science ®Google Scholar
• WITTIG BM, KAULEN H, THEES R et al.: Elevated serum E-selectin in patients with liver metastases of colorectal cancer. Eur. J. Cancer (1996) 32A(7):1215-1218.
   PubMedGoogle Scholar
• ALEXIOU D, KARAYIANNAKIS AJ, SYRIGOS KN et al.: Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur. J. Cancer (2001) 37(18):2392-2397.
   PubMed Web of Science ®Google Scholar
• ALEXIOU D, KARAYIANNAKIS AJ, SYRIGOS KN et al.: Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am. J. Gastroenterol. (2003) 98(2):478-485.
   PubMed Web of Science ®Google Scholar
• ZHANG GJ, ADACHI I: Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis. Int. J. Oncol. (1999) 14(1):71-77.
   PubMed Web of Science ®Google Scholar
• HEBBAR M, PEYRAT JP: Significance of soluble endothelial molecule E-selectin in patients with breast cancer. Int. J. Biol. Markers (2000) 15(1):15-21.
   PubMedGoogle Scholar
• ITO K, YE CL, HIBI K et al.: Paired tumor marker of soluble E-selectin and its ligand sialyl Lewis A in colorectal cancer. J. Gastroenterol. (2001) 36(12):823-829.
   PubMedGoogle Scholar
• UNER A, AKCALI Z, UNSAL D: Serum levels of soluble E-selectin in colorectal cancer. Neoplasma (2004) 51(4):269-274.
   PubMed Web of Science ®Google Scholar
• VELIKOVA G, BANKS RE, GEARING A et al.: Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br. J. Cancer (1998) 77(11):1857-1863.
   PubMed Web of Science ®Google Scholar
• HEBBAR M, REVILLION F, LOUCHEZ MM et al.: The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer. Clin. Cancer Res. (1998) 4(2):373-380.
   PubMed Web of Science ®Google Scholar
• CERVELLO M, VIRRUSO L, LIPANI G et al.: Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. (2000) 126(6):345-351.
   PubMedGoogle Scholar
• FUHLBRIGGE RC, WEISHAUPT C: Adhesion molecules in cutaneous immunity. Semin. Immunopathol. (2007) 29(1):45-57.
   PubMedGoogle Scholar
• EPPIHIMER MJ, SCHAUB RG: Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules. Microcirculation (2001) 8(1):15-24.
   PubMedGoogle Scholar
• SAKO D, COMESS KM, BARONE KM et al.: A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell (1995) 83(2):323-331.
   PubMed Web of Science ®Google Scholar
• HICKS AE, NOLAN SL, RIDGER VC, HELLEWELL PG, NORMAN KE: Recombinant P-selectin glycoprotein ligand-1 directly inhibits leukocyte rolling by all 3 selectins in vivo: complete inhibition of rolling is not required for anti-inflammatory effect. Blood (2003) 101(8):3249-3256.
   PubMed Web of Science ®Google Scholar
• SCALIA R, HAYWARD R, ARMSTEAD VE, MINCHENKO AG, LEFER AM: Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte–endothelium interaction in vivo. Role in rat traumatic shock. Circ. Res. (1999) 84(1):93-102.
   PubMedGoogle Scholar
• SCALIA R, ARMSTEAD VE, MINCHENKO AG, LEFER AM: Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J. Exp. Med. (1999) 189(6):931-938.
   PubMedGoogle Scholar
• HAYWARD R, LEFER AM: Acute mesenteric ischemia and reperfusion: protective effects of recombinant soluble P-selectin glycoprotein ligand-1. Shock (1999) 12(3):201-207.
   PubMed Web of Science ®Google Scholar
• HAYWARD R, CAMPBELL B, SHIN YK, SCALIA R, LEFER AM: Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc. Res. (1999) 41(1):65-76.
   PubMed Web of Science ®Google Scholar
• KYRIAKIDES C, AUSTEN W Jr, WANG Y et al.: Endothelial selectin blockade attenuates lung permeability of experimental acid aspiration. Surgery (2000) 128(2):327-331.
   PubMedGoogle Scholar
• BANNERT N, CRAIG S, FARZAN M et al.: Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J. Exp. Med. (2001) 194(11):1661-1673.
   PubMedGoogle Scholar
• VEERMAN KM, WILLIAMS MJ, UCHIMURA K et al.: Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs. Nat. Immunol. (2007) 8(5):532-539.
   PubMedGoogle Scholar
• COMPAIN P, MARTIN OR: Carbohydrate mimetics-based glycosyltransferase inhibitors. Bioorg. Med. Chem. (2001) 9(12):3077-3092.
   PubMed Web of Science ®Google Scholar
• MITCHELL ML, TIAN F, LEE LV, WONG CH: Synthesis and evaluation of transition-state analogue inhibitors of α-1,3-fucosyltransferase. Angew. Chem. Int. Ed. Engl. (2002) 41(16):3041-3044.
   PubMedGoogle Scholar
• MURRAY BW, TAKAYAMA S, SCHULTZ J, WONG CH: Mechanism and specificity of human α-1,3-fucosyltransferase V. Biochemistry (1996) 35(34):11183-11195.
   PubMedGoogle Scholar
• MIURA Y, KIM S, ETCHISON JR et al.: Aglycone structure influences α-fucosyltransferase III activity using N-acetyllactosamine glycoside acceptors. Glycoconj. J. (1999) 16(11):725-730.
   PubMedGoogle Scholar
• DE VRIES T, PALCIC MP, SCHOENMAKERS PS, VAN DEN EIJNDEN DH, JOZIASSE DH: Acceptor specificity of GDP-Fuc:Gal β1–>4GlcNAc-R α3-fucosyltransferase VI (FucT-VI) expressed in insect cells as soluble, secreted enzyme. Glycobiology (1997) 7(7):921-927.
   PubMedGoogle Scholar
• LEE LV, MITCHELL ML, HUANG SJ et al.: A potent and highly selective inhibitor of human α-1,3-fucosyltransferase via click chemistry. J. Am. Chem. Soc. (2003) 125(32):9588-9589.
   PubMed Web of Science ®Google Scholar
• BRYAN MC, LEE LV, WONG CH: High-throughput identification of fucosyltransferase inhibitors using carbohydrate microarrays. Bioorg. Med. Chem. Lett. (2004) 14(12):3185-3188.
   PubMedGoogle Scholar
• BENGTSON P, LUNDBLAD A, LARSON G, PAHLSSON P: Polymorphonuclear leukocytes from individuals carrying the G329A mutation in the α1,3-fucosyltransferase VII gene (FUT7) roll on E- and P-selectins. J. Immunol. (2002) 169(7):3940-3946.
   PubMed Web of Science ®Google Scholar
• DESCHENY L, GAINERS ME, WALCHECK B, DIMITROFF CJ: Ameliorating skin-homing receptors on malignant T cells with a fluorosugar analog of N-acetylglucosamine: P-selectin ligand is a more sensitive target than E-selectin ligand. J. Invest. Dermatol. (2006) 126(9):2065-2073.
   PubMedGoogle Scholar
• DIMITROFF CJ, KUPPER TS, SACKSTEIN R: Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. J. Clin. Invest. (2003) 112(7):1008-1018.
   PubMed Web of Science ®Google Scholar
• SPEVAK W, FOXALL C, CHARYCH DH, DASGUPTA F, NAGY JO: Carbohydrates in an acidic multivalent assembly: nanomolar P-selectin inhibitors. J. Med. Chem. (1996) 39(5):1018-1020.
   PubMedGoogle Scholar
• CAPPI MW, MOREE WJ, QIAO L et al.: Synthesis of novel 6-amido-6-deoxy-L-galactose derivatives as sialyl Lewis X mimetics. Bioorg. Med. Chem. (1997) 5(2):283-296.
   PubMedGoogle Scholar
• MUROHARA T, MARGIOTTA J, PHILLIPS LM et al.: Cardioprotection by liposome-conjugated sialyl LewisX-oligosaccharide in myocardial ischaemia and reperfusion injury. Cardiovasc. Res. (1995) 30(6):965-974.
   PubMed Web of Science ®Google Scholar
• FRIEDRICH M, BOCK D, PHILIPP S et al.: Pan-selectin antagonism improves psoriasis manifestation in mice and man. Arch. Dermatol. Res. (2006) 297(8):345-351.
   PubMed Web of Science ®Google Scholar
• OOSTINGH GJ, LUDWIG RJ, ENDERS S et al.: Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functions. J. Invest. Dermatol. (2007) 127(1):90-97.
   PubMedGoogle Scholar
• SCHON MP, KRAHN T, SCHON M et al.: Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat. Med. (2002) 8(4):366-372.
   PubMed Web of Science ®Google Scholar
• LUDWIG RJ, ALBAN S, BISTRIAN R et al.: The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo. Thromb. Haemost. (2006) 95(3):535-540.
   PubMed Web of Science ®Google Scholar
• STEVENSON JL, CHOI SH, VARKI A: Differential metastasis inhibition by clinically relevant levels of heparins – correlation with selectin inhibition, not antithrombotic activity. Clin. Cancer Res. (2005) 11(19 Part 1):7003-7011.
   PubMed Web of Science ®Google Scholar
• SARKAR AK, FRITZ TA, TAYLOR WH, ESKO JD: Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Galβ1–>4GlcNAc β-O-naphthalenemethanol. Proc. Natl. Acad. Sci. USA (1995) 92(8):3323-3327.
   PubMedGoogle Scholar
• SARKAR AK, ROSTAND KS, JAIN RK, MATTA KL, ESKO JD: Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion. J. Biol. Chem. (1997) 272(41):25608-25616.
   PubMedGoogle Scholar
• SARKAR AK, BROWN JR, ESKO JD: Synthesis and glycan priming activity of acetylated disaccharides. Carbohydr. Res. (2000) 329(2):287-300.
   PubMed Web of Science ®Google Scholar
• LEY K, BULLARD DC, ARBONES ML et al.: Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J. Exp. Med. (1995) 181(2):669-675.
   PubMed Web of Science ®Google Scholar
• OLOFSSON AM, ARFORS KE, RAMEZANI L et al.: E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules. Blood (1994) 84(8):2749-2758.
   PubMed Web of Science ®Google Scholar
• YAO L, SETIADI H, XIA L et al.: Divergent inducible expression of P-selectin and E-selectin in mice and primates. Blood (1999) 94(11):3820-3828.
   PubMedGoogle Scholar
• LABOW MA, NORTON CR, RUMBERGER JM et al.: Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. Immunity (1994) 1(8):709-720.
   PubMed Web of Science ®Google Scholar
• LOWENSTEIN CJ, MORRELL CN, YAMAKUCHI M: Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc. Med. (2005) 15(8):302-308.
   PubMedGoogle Scholar
• MERTEN M, THIAGARAJAN P: P-selectin in arterial thrombosis. Z. Kardiol. (2004) 93(11):855-863.
   PubMedGoogle Scholar
• GUNDEL RH, WEGNER CD, TORCELLINI CA et al.: Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys. J. Clin. Invest. (1991) 88(4):1407-1411.
   PubMed Web of Science ®Google Scholar
• MULLIGAN MS, VARANI J, DAME MK et al.: Role of endothelial–leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J. Clin. Invest. (1991) 88(4):1396-1406.
   PubMed Web of Science ®Google Scholar
• GROBER JS, BOWEN BL, EBLING H et al.: Monocyte–endothelial adhesion in chronic rheumatoid arthritis. In situ detection of selectin and integrin-dependent interactions. J. Clin. Invest. (1993) 91(6):2609-2619.
   PubMed Web of Science ®Google Scholar
• KOCH AE, BURROWS JC, HAINES GK et al.: Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab. Invest. (1991) 64(3):313-320.
   PubMed Web of Science ®Google Scholar
• ALLEN MD, MCDONALD TO, HIMES VE et al.: E-selectin expression in human cardiac grafts with cellular rejection. Circulation (1993) 88(5 Part 2):II243-II247.
   PubMedGoogle Scholar
• BORSIG L, WONG R, HYNES RO, VARKI NM, VARKI A: Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl. Acad. Sci. USA (2002) 99(4):2193-2198.
   PubMed Web of Science ®Google Scholar
• BARTHOLDY C, MARKER O, THOMSEN AR: Migration of activated CD8(+) T lymphocytes to sites of viral infection does not require endothelial selectins. Blood (2000) 95(4):1362-1369.
   PubMedGoogle Scholar